Androgen upregulates the palmitoylation of eIF3L in human prostate LNCaP cells

Background: Prostate cancer is the second leading cause of cancer-related deaths in Western countries. Most patients diagnosed with advanced prostate cancer can be treated with the main treatment: androgen deprivation therapy (ADT). The androgen receptor (AR) signaling axis plays a pivotal role in t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Onco Targets Ther
Hauptverfasser: Cui, Luwei, Liu, Ming, Lai, Shicong, Hou, Huimin, Diao, Tongxiang, Zhang, Dalei, Wang, Miao, Zhang, Yaoguang, Wang, Jianye
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove 2019
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6556480/
https://ncbi.nlm.nih.gov/pubmed/31239713
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S193480
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge